Raymond James Financial Services Advisors, Inc. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$20,206
-43.2%
11,956
-6.6%
0.00%
Q2 2023$35,601
+40.6%
12,806
-8.0%
0.00%
Q1 2023$25,323
-61.6%
13,914
+6.9%
0.00%
Q4 2022$65,981
-8.4%
13,014
-10.3%
0.00%
Q3 2022$72,000
+41.2%
14,514
+6.6%
0.00%
Q2 2022$51,00013,6210.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders